Economics Faculty Database
Economics
Arts & Sciences
Duke University
 HOME > Arts & Sciences > Economics > Faculty    Search Help Login pdf version printable version 

Publications of Shelby Reed    :chronological  alphabetical  combined  bibtex listing:

Papers Published

  1. MA Dinan, TJ Robinson, TM Zagar, CD Scales Jr, LH Curtis, SD Reed, WR Lee, KA Schulman, Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007., International journal of radiation oncology, biology, physics, vol. 82 no. 5 (April, 2012), pp. e781-6, ISSN 1879-355X [doi]  [abs]
  2. EM Dewitt, CA Grussemeyer, JY Friedman, MA Dinan, L Lin, KA Schulman, SD Reed, Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 15 no. 2 (January, 2012), pp. 277-83, ISSN 1524-4733 [doi]  [abs]
  3. SD Reed, Y Li, S Kamble, D Polsky, FL Graham, MT Bowers, GP Samsa, S Paul, KA Schulman, DJ Whellan, BJ Riegel, Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions., Circulation. Cardiovascular quality and outcomes, vol. 5 no. 1 (January, 2012), pp. 113-9, ISSN 1941-7705 [doi]  [abs]
  4. SD Reed, When evaluating parameter uncertainty is not enough: the case of dasatinib and nilotinib for imatinib-resistant chronic myeloid leukemia., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 14 no. 8 (December, 2011), pp. 1055-6, ISSN 1524-4733 [doi]
  5. SD Reed, ZJ Eapen, KA Schulman, End point selection in acute decompensated heart failure clinical trials: economic end points., Heart failure clinics, vol. 7 no. 4 (October, 2011), pp. 529-37, ISSN 1551-7136 [doi]  [abs]
  6. ZJ Eapen, SD Reed, LH Curtis, AF Hernandez, ED Peterson, Do heart failure disease management programs make financial sense under a bundled payment system?, American heart journal, vol. 161 no. 5 (May, 2011), pp. 916-22, ISSN 1097-6744 [doi]  [abs]
  7. SD Reed, CD Scales Jr, SB Stewart, J Sun, JW Moul, KA Schulman, J Xu, Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer., The Journal of urology, vol. 185 no. 3 (March, 2011), pp. 841-7, ISSN 1527-3792 [doi]  [abs]
  8. M Barbieri, M Drummond, F Rutten, J Cook, HA Glick, J Lis, SD Reed, M Sculpher, JL Severens, ISPOR Good Research Practices Economic Data Transferability Task Force, What do international pharmacoeconomic guidelines say about economic data transferability?, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 13 no. 8 (December, 2010), pp. 1028-37, ISSN 1524-4733 [doi]  [abs]
  9. CH Chou, SD Reed, JS Allsbrook, JL Steele, KA Schulman, MJ Alexander, Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage., Neurosurgery, vol. 67 no. 2 (August, 2010), pp. 345-51; discussion 351-2, ISSN 1524-4040 [doi]  [abs]
  10. DJ Anderson, JM Arduino, SD Reed, DJ Sexton, KS Kaye, CA Grussemeyer, SA Peter, C Hardy, YI Choi, JY Friedman, VG Fowler Jr, Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, vol. 31 no. 7 (July, 2010), pp. 701-9, ISSN 1559-6834 [doi]  [abs]
  11. SD Reed, DJ Whellan, Y Li, JY Friedman, SJ Ellis, IL Piña, SJ Settles, L Davidson-Ray, JL Johnson, LS Cooper, CM O'Connor, KA Schulman, HF-ACTION Investigators, Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure., Circulation. Cardiovascular quality and outcomes, vol. 3 no. 4 (July, 2010), pp. 374-81, ISSN 1941-7705 [doi]  [abs]
  12. BT Vaughn, SR DeVrieze, SD Reed, KA Schulman, Can we close the income and wealth gap between specialists and primary care physicians?, Health affairs (Project Hope), vol. 29 no. 5 (May, 2010), pp. 933-40, ISSN 1544-5208 [doi]  [abs]
  13. SD Reed, Y Li, EZ Oddone, AM Neary, MM Orr, JM Grubber, FL Graham, MK Olsen, LP Svetkey, RJ Dolor, BJ Powers, MB Adams, HB Bosworth, Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension., American journal of hypertension, vol. 23 no. 2 (February, 2010), pp. 142-8, ISSN 1941-7225 [doi]  [abs]
  14. C Moran, CA Grussemeyer, JR Spalding, DK Benjamin Jr, SD Reed, Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections., American journal of infection control, vol. 38 no. 1 (February, 2010), pp. 78-80, ISSN 1527-3296 [doi]  [abs]
  15. S Kamble, MJ Telen, MA Dinan, CA Grussemeyer, SD Reed, Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement., American journal of hematology, vol. 85 no. 1 (January, 2010), pp. 79-81, ISSN 1096-8652 [doi]
  16. ME Patterson, WC Grant, SW Glickman, BM Massie, SE Ammon, PW Armstrong, JG Cleland, JF Collins, KK Teo, KA Schulman, SD Reed, Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation., Journal of cardiac failure, vol. 15 no. 10 (December, 2009), pp. 819-27, ISSN 1532-8414 [doi]  [abs]
  17. MA Dinan, CH Chou, BG Hammill, FL Graham, KA Schulman, MJ Telen, SD Reed, Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures., American journal of hematology, vol. 84 no. 11 (November, 2009), pp. 703-9, ISSN 1096-8652 [doi]  [abs]
  18. HB Bosworth, MK Olsen, JM Grubber, AM Neary, MM Orr, BJ Powers, MB Adams, LP Svetkey, SD Reed, Y Li, RJ Dolor, EZ Oddone, Two Self-management Interventions to Improve Hypertension Control: A Randomized Trial., Annals of internal medicine, vol. 151 no. 10 (November, 2009), pp. 687-695, ISSN 1539-3704  [abs]
  19. HB Bosworth, MK Olsen, JM Grubber, AM Neary, MM Orr, BJ Powers, MB Adams, LP Svetkey, SD Reed, Y Li, RJ Dolor, EZ Oddone, Two Self-management Interventions to Improve Hypertension Control: A Randomized Trial., Annals of internal medicine (October, 2009), ISSN 1539-3704  [abs]
  20. EM DeWitt, L Lin, HA Glick, KJ Anstrom, KA Schulman, SD Reed, Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank., Clinical therapeutics, vol. 31 no. 8 (August, 2009), pp. 1871-80; discussion 1858, ISSN 1879-114X [doi]  [abs]
  21. M Drummond, M Barbieri, J Cook, HA Glick, J Lis, F Malik, SD Reed, F Rutten, M Sculpher, J Severens, Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 12 no. 4 (June, 2009), pp. 409-18, ISSN 1524-4733 [doi]  [abs]
  22. SD Reed, KA Schulman, Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 12 no. 5 (May, 2009), pp. 637-40, ISSN 1524-4733 [doi]
  23. C Moran, CA Grussemeyer, JR Spalding, DK Benjamin Jr, SD Reed, Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs., The Pediatric infectious disease journal, vol. 28 no. 5 (May, 2009), pp. 433-5, ISSN 0891-3668 [doi]  [abs]
  24. SD Reed, Y Li, KJ Anstrom, KA Schulman, Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 27 no. 13 (May, 2009), pp. 2185-91, ISSN 1527-7755 [doi]  [abs]
  25. Y Li, JY Friedman, BF O'Neal, MJ Hohenboken, RI Griffiths, ME Stryjewski, JP Middleton, KA Schulman, JK Inrig, VG Fowler Jr, SD Reed, Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients., Clinical journal of the American Society of Nephrology : CJASN, vol. 4 no. 2 (February, 2009), pp. 428-34, ISSN 1555-905X [doi]  [abs]
  26. SD Reed, KJ Anstrom, DM Seils, RM Califf, KA Schulman, Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs., Health affairs (Project Hope), vol. 27 no. 5 (August, 2008), pp. w360-70, ISSN 1544-5208 [doi]  [abs]
  27. T Lalani, VH Chu, CA Grussemeyer, SD Reed, MP Bolognesi, JY Friedman, RI Griffiths, DR Crosslin, ZA Kanafani, KS Kaye, G Ralph Corey, VG Fowler, Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections., Scandinavian journal of infectious diseases (July, 2008), pp. 1-5, ISSN 0036-5548  [abs]
  28. T Takahashi, SD Reed, KA Schulman, Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease., Nephrology (Carlton, Vic.) (June, 2008), ISSN 1440-1797  [abs]
  29. CE Cox, SD Reed, JA Govert, JE Rodgers, S Campbell-Bright, JP Kress, SS Carson, Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation., Critical care medicine, United States, vol. 36 no. 3 (March, 2008), pp. 706-14, ISSN 1530-0293  [abs]
  30. SD Reed, AM Shea, KA Schulman, Economic implications of potential changes to regulatory and reimbursement policies for medical devices., Journal of general internal medicine, vol. 23 Suppl 1 (January, 2008), pp. 50-6, ISSN 1525-1497 [doi]  [abs]
  31. SD Reed, KJ Anstrom, Y Li, KA Schulman, Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia., PharmacoEconomics, vol. 26 no. 5 (2008), pp. 435-46, ISSN 1170-7690  [abs]
  32. AM Shea, SD Reed, LH Curtis, MJ Alexander, JJ Villani, KA Schulman, Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003., Neurosurgery, United States, vol. 61 no. 6 (December, 2007), pp. 1131-7; discussion 1137-8, ISSN 1524-4040  [abs]
  33. SD Reed, RM Califf, KA Schulman, How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation., Health affairs (Project Hope), vol. 25 no. 5 (March, 2007), pp. 1309-17, ISSN 1544-5208 [doi]  [abs]
  34. DJ Whellan, SD Reed, L Liao, SD Gould, CM O'connor, KA Schulman, Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives., The American journal of cardiology, United States, vol. 99 no. 2 (January, 2007), pp. 256-60, ISSN 0002-9149  [abs]
  35. Reed SD, Califf RM, Schulman KA. Is there a price to pay for short-term savings in the clinical development of new pharmaceutical products? Drug Inf J. 2007;41:491-499.
  36. FM Torti Jr, SD Reed, KA Schulman, Analytic considerations in economic evaluations of multinational cardiovascular clinical trials., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 9 no. 5 (October, 2006), pp. 281-91, ISSN 1098-3015 [doi]  [abs]
  37. SD Reed, JJ McMurray, EJ Velazquez, KA Schulman, RM Califf, L Kober, AP Maggioni, F Van de Werf, HD White, R Diaz, V Mareev, J Murin, VALIANT Committees and Investigators, Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial., American heart journal, vol. 152 no. 3 (September, 2006), pp. 500-8, ISSN 1097-6744 [doi]  [abs]
  38. JK Inrig, SD Reed, LA Szczech, JJ Engemann, JY Friedman, GR Corey, KA Schulman, LB Reller, VG Fowler, Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia., Clinical journal of the American Society of Nephrology : CJASN, United States, vol. 1 no. 3 (May, 2006), pp. 518-24, ISSN 1555-905X  [abs]
  39. BD Alexander, ED Ashley, LB Reller, SD Reed, Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures., Diagnostic microbiology and infectious disease, United States, vol. 54 no. 4 (April, 2006), pp. 277-82, ISSN 0732-8893  [abs]
  40. SD Reed, JI Radeva, DB Daniel, SH Mody, JB Forlenza, RS McKenzie, KA Schulman, Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial., PharmacoEconomics, vol. 24 no. 5 (2006), pp. 479-94, ISSN 1170-7690  [abs]
  41. VH Chu, DR Crosslin, JY Friedman, SD Reed, CH Cabell, RI Griffiths, LE Masselink, KS Kaye, GR Corey, LB Reller, ME Stryjewski, KA Schulman, VG Fowler, Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes., The American journal of medicine, United States, vol. 118 no. 12 (December, 2005), pp. 1416, ISSN 1555-7162  [abs]
  42. SD Reed, JI Radeva, DB Daniel, JM Fastenau, D Williams, KA Schulman, Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia., Current medical research and opinion, vol. 21 no. 10 (October, 2005), pp. 1527-33, ISSN 0300-7995 [doi]  [abs]
  43. J Chang, TL Kauf, S Mahajan, JM Jordan, VB Kraus, TP Vail, SD Reed, MA Omar, KH Kahler, KA Schulman, Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis., Arthritis and rheumatism, United States, vol. 52 no. 8 (August, 2005), pp. 2366-75, ISSN 0004-3591  [abs]
  44. SD Reed, JI Radeva, KP Weinfurt, JJ McMurray, MA Pfeffer, EJ Velazquez, JS Allsbrook, LE Masselink, MA Sellers, RM Califf, KA Schulman, VALIANT Investigators, Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)., American heart journal, vol. 150 no. 2 (August, 2005), pp. 323-9, ISSN 1097-6744 [doi]  [abs]
  45. JJ Engemann, JY Friedman, SD Reed, RI Griffiths, LA Szczech, KS Kaye, ME Stryjewski, LB Reller, KA Schulman, GR Corey, VG Fowler, Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, United States, vol. 26 no. 6 (June, 2005), pp. 534-9, ISSN 0899-823X  [abs]
  46. SD Reed, KJ Anstrom, A Bakhai, AH Briggs, RM Califf, DJ Cohen, MF Drummond, HA Glick, A Gnanasakthy, MA Hlatky, BJ O'Brien, FM Torti Jr, AA Tsiatis, AR Willan, DB Mark, KA Schulman, Conducting economic evaluations alongside multinational clinical trials: toward a research consensus., American heart journal, vol. 149 no. 3 (March, 2005), pp. 434-43, ISSN 1097-6744 [doi]  [abs]
  47. JI Radeva, SD Reed, Z Kaló, TL Kauf, E Cantu, N Cretin, KA Schulman, Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation., Clinical transplantation, Denmark, vol. 19 no. 1 (February, 2005), pp. 122-9, ISSN 0902-0063  [abs]
  48. SD Reed, JI Radeva, GA Glendenning, RE Coleman, KA Schulman, Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma., American journal of clinical oncology, United States, vol. 28 no. 1 (February, 2005), pp. 8-16, ISSN 1537-453X  [abs]
  49. SD Reed, JY Friedman, JJ Engemann, RI Griffiths, KJ Anstrom, KS Kaye, ME Stryjewski, LA Szczech, LB Reller, GR Corey, KA Schulman, VG Fowler Jr, Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, vol. 26 no. 2 (February, 2005), pp. 175-83, ISSN 0899-823X [doi]  [abs]
  50. MM Kitahata, SD Reed, PW Dillingham, SE Van Rompaey, AA Young, RD Harrington, KK Holmes, Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death., International journal of STD & AIDS, England, vol. 15 no. 12 (December, 2004), pp. 803-10, ISSN 0956-4624  [abs]
  51. KJ Anstrom, SD Reed, AS Allen, GA Glendenning, KA Schulman, Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia., Cancer, vol. 101 no. 11 (December, 2004), pp. 2584-92, ISSN 0008-543X [doi]  [abs]
  52. SD Reed, KJ Anstrom, JA Ludmer, GA Glendenning, KA Schulman, Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia., Cancer, vol. 101 no. 11 (December, 2004), pp. 2574-83, ISSN 0008-543X [doi]  [abs]
  53. JY Friedman, SD Reed, KP Weinfurt, KH Kahler, EB Walter, KA Schulman, Parents' reported preference scores for childhood atopic dermatitis disease states., BMC pediatrics, England, vol. 4 no. 1 (October, 2004), pp. 21, ISSN 1471-2431  [abs]
  54. SD Reed, JY Friedman, EJ Velazquez, A Gnanasakthy, RM Califf, KA Schulman, Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)., American heart journal, United States, vol. 148 no. 1 (July, 2004), pp. 122-8, ISSN 1097-6744  [abs]
  55. SD Reed, JI Radeva, GA Glendenning, F Saad, KA Schulman, Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer., The Journal of urology, United States, vol. 171 no. 4 (April, 2004), pp. 1537-42, ISSN 0022-5347  [abs]
  56. SD Reed, TA Lee, DC McCrory, The economic burden of allergic rhinitis: a critical evaluation of the literature., PharmacoEconomics, New Zealand, vol. 22 no. 6 (2004), pp. 345-61, ISSN 1170-7690  [abs]
  57. SD Reed, PW Dillingham, AH Briggs, DL Veenstra, SD Sullivan, A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results., Medical decision making : an international journal of the Society for Medical Decision Making, vol. 23 no. 3 (September, 2003), pp. 252-64, ISSN 0272-989X  [abs]
  58. KA Schulman, EA Stadtmauer, SD Reed, HA Glick, LJ Goldstein, JM Pines, JA Jackman, S Suzuki, MJ Styler, PA Crilley, TR Klumpp, KF Mangan, JH Glick, Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer., Bone marrow transplantation, England, vol. 31 no. 3 (February, 2003), pp. 205-10, ISSN 0268-3369  [abs]
  59. AW Law, SD Reed, JS Sundy, KA Schulman, Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey., The Journal of allergy and clinical immunology, United States, vol. 111 no. 2 (February, 2003), pp. 296-300, ISSN 0091-6749  [abs]
  60. SD Reed, JY Friedman, A Gnanasakthy, KA Schulman, Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial., International journal of technology assessment in health care, vol. 19 no. 2 (2003), pp. 396-406, ISSN 0266-4623  [abs]
  61. BR Shah, SD Reed, J Francis, DB Ridley, KA Schulman, The cost of inefficiency in US hospitals, 1985-1997., Journal of health care finance, United States, vol. 30 no. 1 (2003), pp. 1-9, ISSN 1078-6767  [abs]
  62. JE Onken, JY Friedman, S Subramanian, KP Weinfurt, SD Reed, JH Malenbaum, T Schmidt, KA Schulman, Treatment patterns and costs associated with sessile colorectal polyps., The American journal of gastroenterology, United States, vol. 97 no. 11 (November, 2002), pp. 2896-901, ISSN 0002-9270  [abs]
  63. SD Reed, R Laxminarayan, DJ Black, SD Sullivan, Economic issues and antibiotic resistance in the community., The Annals of pharmacotherapy, United States, vol. 36 no. 1 (January, 2002), pp. 148-54, ISSN 1060-0280  [abs]
  64. Reed SD, Laxminarayan R, Black DJ, Sullivan SD. Economic Issues and Microbial Resistance to Antibiotics. Ann of Pharmacother. 2002; 36: 148-54.
  65. Reed SD, Blough DK, Meyer K, Jarvik JG. Inpatient Costs, Length of Stay and Mortality for Cerebrovascular Events in Community Hospitals, Neurology 2001; 57: 305-314.
  66. Mullins CD, Ogilvie SD. Emerging standardization in pharmacoeconomics, Clinical Therapeutics 1998; 20: 1194-1202.
  67. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with Tissue Plasminogen Activator and Inpatient Mortality in Ischemic Stroke Patients Treated in Community Hospitals, Stroke 2001; 32: 1832-40.
  68. Reed SO, Mullins CD, Magder LS. Cost-effectiveness of abciximab during routine medical practice, Pharmacoeconomics 2000; 18: 265-74.
  69. Ogilvie SD, Mullins CD, Roffman DS, Mays DA. Editorial: Difficulties in applying clinical trial information to the practice setting: Case of a high-cost drug. Am J Health-Syst Pharm 1998; 55: 2409-14.
  70. Mullins CD, Stockwell Morris L, Perfetto EM, Ogilvie SD. NSAIDS: Beyond Bleeds. J Managed Care Pharm 1997; 3: 425-30.
  71. Reed SD, Sullivan SD, Laxminarayan R. Economic Issues Related to Antibiotic Use in Appropriate Antibiotic Use- Proceedings of a LIBRA Meeting. International Congress and Symposium Series 251. The Royal Society of Medicine Press Limited: London, 2001:pp 43-48.
  72. SD Reed, SC Cramer, DK Blough, K Meyer, JG Jarvik, Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals., Stroke; a journal of cerebral circulation, United States, vol. 32 no. 8 (August, 2001), pp. 1832-40, ISSN 1524-4628  [abs]
  73. SD Reed, DK Blough, K Meyer, JG Jarvik, Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals., Neurology, United States, vol. 57 no. 2 (July, 2001), pp. 305-14, ISSN 0028-3878  [abs]
  74. Reed SD, Blough DK, Meyer K, Jarvik JG. Inpatient Costs, Length of Stay and Mortality for Cerebrovascular Events in Community Hospitals, Neurology 2001; 57: 305-314.
  75. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with Tissue Plasminogen Activator and Inpatient Mortality in Ischemic Stroke Patients Treated in Community Hospitals, Stroke 2001; 32: 1832-40.
  76. Reed SO, Mullins CD, Magder LS. Cost-effectiveness of abciximab during routine medical practice, Pharmacoeconomics 2000;18:265-74.
  77. Reed SO, Mullins CD, Magder LS. Cost-effectiveness of abciximab during routine medical practice, Pharmacoeconomics 2000; 18: 265-74.
  78. SD Reed, CD Mullins, DS Roffman, DA Mays, Difficulties in applying clinical trial information to the practice setting: case of a high-cost drug., American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, UNITED STATES, vol. 55 no. 22 (November, 1998), pp. 2409-14, ISSN 1079-2082
  79. Ogilvie SD, Mullins CD, Roffman DS, Mays DA. Editorial: Difficulties in applying clinical trial information to the practice setting: Case of a high-cost drug. Am J Health-Syst Pharm 1998;55:2409-14.
  80. Mullins CD, Ogilvie SD.  Emerging standardization in pharmacoeconomics,  Clinical Therapeutics 1998; 20: 1194-1202.
  81. Mullins CD, Ogilvie SD. Emerging standardization in pharmacoeconomics, Clinical Therapeutics 1998;20:1194-1202.
  82. Mullins CD, Stockwell Morris L, Perfetto EM, Ogilvie SD. NSAIDS: Beyond Bleeds. J Managed Care Pharm 1997;3:425-30.
  83. MN Hantas, ES Katkin, SD Reed, Cerebral lateralization and heartbeat discrimination., Psychophysiology, vol. 21 no. 3 (May, 1984), pp. 274-8, ISSN 0048-5772
  84. FM Torti, LP Gwyther, SD Reed, JY Friedman, KA Schulman, A multinational review of recent trends and reports in dementia caregiver burden., Alzheimer disease and associated disorders, United States, vol. 18 no. 2 , pp. 99-109, ISSN 0893-0341  [abs]
Duke University * Arts & Sciences * Economics * Faculty * Research * Staff * Master's * Ph.D. * Reload * Login